SciELO - Scientific Electronic Library Online

 
vol.38 issue4Medication non-adherence as a cause of hospital admissionsReview of pharmacological interactions of oral anticancer drugs provided at pharmacy department author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Farmacia Hospitalaria

On-line version ISSN 2171-8695Print version ISSN 1130-6343

Abstract

MUROS-ORTEGA, M.; RAMOS, R.  and  MOLINA, M.. Toward a new model of pharmacy management comprehensive care of patients with chronic kidney disease. Farm Hosp. [online]. 2014, vol.38, n.4, pp.334-337. ISSN 2171-8695.  https://dx.doi.org/10.7399/FH.2014.38.4.7297.

Objective: The treatment of chronic kidney disease represents 2.5% of the National Healthcare System budget. Given the panorama of economic crisis, actions aimed at containing the costs in this kind of pathologies should be implemented. Method: Centralization of the management of the medications used for the treatment of chronic kidney disease and its complications aims at reducing the pharmaceutical expenditure. Results: The new contracts of public healthcare administrations with companies of dialysis centers establish a single price by which the contractor takes care of the integral management of the patients, including the dialysis therapy and pharmacological treatment. Drug management at dialysis centers will be handled by specialized pharmacists by means of the creation of pharmacy departments or drug warehouse. Conclusions: these measures aim at improving healthcare of the patient in hemodialysis program, with health benefits at a lower healthcare cost.

Keywords : Chronic kidney disease; Comprehensive health care; Pharmaceutical care.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License